The phenomena of the initial sessions: The patient's experience of the relationship and the effects of therapist interventions on the therapeutic alliance during
the opening phase of treatment.
Not exact matches
A
Phase 3
Open - Label Randomized Study
of Quizartinib (AC220) Monotherapy Versus Salvage Chemotherapy in Subjects with FLT3 - ITD Positive Acute Myeloid Leukemia (AML) Refractory To or Relapsed After First - line
Treatment With or Without Hematopoietic Stem Cell Transplantation (HSCT) Consolidation
14255: STAT3 Signaling During Chemo - Radiation for Squamous Cell Carcinoma
of the Head and Neck 14340: A
Phase II, Randomized,
Open - Label, Multi-Center, Global Study
of MEDI4736 Monotherapy, Tremelimumab Monotherapy, and MEDI4736 in Combination with Tremelimumab in Patients with Recurrent or Metastatic Squamous Cell Carcinoma
of the Head and Neck (SCCHN) 14258: Randomized
Phase II and
Phase III Studies
of Individualized
Treatment for Nasopharyngeal Carcinoma Based on Biomarker Epstein Barr Virus (EBV) Deoxyribonucleic Acid (DNA)
A
Phase III,
Open Label, Randomized Study to Assess the Efficacy and Safety
of Olaparib (Lynparza) versus Enzalutamide or Abiraterone Acetate in Men with Metastatic Castration - Resistant Prostate Cancer who have Failed Prior
Treatment with a New Hormonal Agent and have Homologous Recombination Repair Gene Mutations.
A
Phase Ib,
Open - Label Study
of the Safety and Tolerability
of Atezolizumab in Combination with Radium - 223 Dichloride in Patients with Castrate - Resistant Prostate Cancer who have Progressed Following
Treatment with an Androgen Pathway Inhibitor
A
Phase 3, Multicenter, Randomized,
Open - Label Study
of Guadecitabine (SGI - 110) versus
Treatment Choice in Adults with Previously Treated Acute Myeloid Leukemia